ArticleACS omega2020
Zeolitic Imidazolate Framework-8-Encapsulated Nanoparticle of Ag/Cu Composites Supported on Graphene Oxide: Synthesis and Antibacterial Activity.
Article in ACS omega, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 12 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
12 citing papers in PubMed, 72 citations in OpenAlex.
- MOF-808/graphene oxide composite as an efficient adsorbent for urea removal: experimental and atomistic study.Scientific reports · 2026Article
- Multifunctional OEO-ZIF-8-HA Nanoparticles for Antibacterial Control on Latex Surfaces and Baby Arugula (Eruca Sativa) Leaves.Journal of food science · 2026Article
- Article
- Silver integrated hybrids and nanocomposites for next-generation biomedicine: Beyond antimicrobial coatings toward smart sense-response-heal platforms.Materials today. Bio · 2025Review
- Phytofabrication of ZIF-8 Using Mangrove Metabolites for Dual Action Against Drug-Resistant Microbes and Breast Cancer Cells.Biomimetics (Basel, Switzerland) · 2025Article
- NIR-Responsive ZIF-8 Metal-Organic Framework Nanohybrids with Photothermal, Antimicrobial, and Osteoinductive Properties to Prevent Implant Infection.Macromolecular bioscience · 2025Article
- Article
- Hollow Fiber-Supported ZIF-8@GO Reinforced Sol-Gel for Preconcentration of Paraquat Before Determination by UV-Vis Spectrophotometry.Journal of analytical methods in chemistry · 2025Article
- Metal-organic framework-interfaced ELISA probe enables ultrasensitive detection of extracellular vesicle biomarkers.Journal of materials chemistry. B · 2024Article
- Synthesis of Metal-Organic Framework-Based ZIF-8@ZIF-67 Nanocomposites for Antibiotic Decomposition and Antibacterial Activities.ACS omega · 2023Article
- ZnO@ZIF-8 Nanoparticles as Nanocarrier of Ciprofloxacin for Antimicrobial Activity.Pharmaceutics · 2023Article
- Effect of the Incorporation of ZIF-8@GO into the Thin-Film Membrane on Salt Rejection and BSA Fouling.Membranes · 2022Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors at 2 institutions in 2 countries.
Funding
No grant is acknowledged in the PubMed record.
Abstract
The rational approach motivated the design of novel antimicrobial silver and silver-copper bimetallic nanoparticles contained within zeolitic imidazolate framework-8 supported on graphene oxide (GO), Ag@ZIF-8@GO, and AgCu@ZIF8@GO. In the resultant composites, ZIF-8 was able to prevent the stacking of GO sheets and also acted as a carrier for the nanoparticles within its cavities. GO, on the other hand, acted as an anchoring support enabling uniform dispersion of the nanocomposites, thus eliminating their aggregation. The morphological and physicochemical properties of the composites were determined through a variety of characterization techniques, for example, transmission electron microscopy, scanning electron microscopy, Fourier-transform infrared spectroscopy, p-X-ray diffraction (XRD), nitrogen sorption, and X-ray photoelectron spectroscopy (XPS). The energy-dispersive system and XPS supplied evidence of the presence of all expected components in the composites. The XRD provided proof of a crystalline, distorted ZIF-8 structure. Ag@ZIF8@GO and Ag-Cu@ZIF-8@GO composites were effective against both Gram-negative (
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.